3-propylsulfanyl-propan-1-ol | 26901-98-4

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 3-propylsulfanyl-propan-1-ol
• 英文别名: 3-Propylmercapto-propan-1-ol；Monothiotrimethylenglykol-S-propylaether；γ-Oxy-dipropylsulfid；3-Propylmercaptopropanol-1；3-(Propylthio)-1-propanol；3-propylsulfanylpropan-1-ol
• CAS: 26901-98-4
• 化学式: C₆H₁₄OS
• 分子量: 134.243
• InChiKey: AUVBKWQJMSXELH-UHFFFAOYSA-N

物化性质

• 沸点：
  112 °C(Press: 16 Torr)
• 密度：
  0.9794 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  8
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  45.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-propylsulfanyl-propan-1-ol 在 氯化亚砜 、 氯仿 、 2,3-二甲基苯胺 作用下， 生成 (3-chloro-propyl)-propyl sulfide
  参考文献：
  名称：

  Bennett; Heathcoat; Mosses, Journal of the Chemical Society, 1929, p. 2570

  摘要：

  DOI：
• 作为产物：
  描述：

  三甲氧基酯 、 丙烷-1-硫醇 在 sodium hydroxide 作用下， 生成 3-propylsulfanyl-propan-1-ol
  参考文献：
  名称：

  The Reactions of Trimethylene Oxide with Mercaptans, Thiophenol and Some Inorganic Sulfur Compounds¹

  摘要：

  DOI：

  10.1021/ja01154a004

文献信息

• PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
  申请人：MIURA Tomoya

  公开号：US20130085132A1

  公开（公告）日：2013-04-04

  The present invention provides a pyrazole compound of the following general Formula [Ib] having SGLT1 inhibitory activity, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and its pharmaceutical use: wherein each symbol is the same as defined in the description.

  本发明提供了一种具有SGLT1抑制活性的下式[Ib]所示的吡唑化合物、或其药物可接受的盐、包含该化合物的药物组合物及其医药用途： 其中每个符号如说明书中所定义。
• [EN] CARBOXYLIC ACID COMPOUNDS IN TREATMENT OF DIABETES MELLITUS<br/>[FR] COMPOSÉS D'ACIDE CARBOXYLIQUE DANS LE TRAITEMENT DU DIABÈTE SUCRÉ
  申请人：FUJIAN HAIXI PHARMACEUTICALS CO LTD

  公开号：WO2015024526A1

  公开（公告）日：2015-02-26

  The invention relates to compounds for increasing GPR40 recetpor activity and application thereof. These compounds include of a compound of Formula (I), pharmaceutically acceptable salts thereof, solvates thereof, isomers thereof, or produgs of the compounds mentioned above, or the mixture of any form above mentioned. The invention also relates to the use of the compounds in manufacturing a medicament for the treatment and/or prevention of diabetes, obesity or for Insulin secretagogue.

  该发明涉及增加GPR40受体活性的化合物及其应用。这些化合物包括公式（I）的化合物，其药学上可接受的盐、溶剂化合物、异构体、上述化合物的前药，或上述任何形式的混合物。该发明还涉及将这些化合物用于制造用于治疗和/或预防糖尿病、肥胖或胰岛素分泌素的药物。
• Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use
  申请人：Sankyo Company Limited

  公开号：EP0536936A1

  公开（公告）日：1993-04-14

  Compounds of formula (I): [in which: R¹, R² and R³ are the same or different and each represents a hydrogen atom, an optionally substituted alkanoyl group or an alkenylcarbonyl group, provided that at least one of R¹, R² and R³ represents an unsubstituted alkanoyl group having from 5 to 24 carbon atoms, said substituted alkanoyl group or said alkenylcarbonyl group; and one of R⁴ and R⁵ represents a hydrogen atom and the other represents a cyano group]; have valuable anti-tumour activity.

  式子（I）的化合物：[其中：R¹、R²和R³相同或不同，每个代表氢原子、可选取代的脂肪酰基团或烯基羰基团，前提是至少有一个R¹、R²和R³代表有5到24个碳原子的未取代脂肪酰基团，或者是所述取代的脂肪酰基团或所述烯基羰基团；R⁴和R⁵中的一个代表氢原子，另一个代表氰基]，具有有价值的抗肿瘤活性。
• CARBOXYLIC ACID COMPOUNDS IN TREATMENT OF DIABETES MELLITUS
  申请人：KANG Xinshan

  公开号：US20160200734A1

  公开（公告）日：2016-07-14

  The invention relates to compounds for increasing QPR40 receptor activity and application thereof. These compounds include of a compound of Formula (I), pharmaceutically acceptable salts thereof, solvates thereof, isomers thereof, or produgs of the compounds mentioned above, or the mixture of any form above mentioned. The invention also relates to the use of the compounds in manufacturing a medicament for the treatment and/or prevention of diabetes, obesity or for Insulin secretagogue.

  本发明涉及增加QPR40受体活性的化合物及其应用。这些化合物包括公式（I）的化合物，其药学上可接受的盐，溶剂合物，异构体或上述化合物的前体，或任何上述形式的混合物。本发明还涉及将这些化合物用于制造治疗和/或预防糖尿病、肥胖症或胰岛素分泌剂的药物。
• Novel heterocyclic substituted benzenes, herbicidal compositions containing them and the use thereof for combating weeds
  申请人：ROHM AND HAAS COMPANY

  公开号：EP0068822A2

  公开（公告）日：1983-01-05

  Compounds of the formula below are disclosed as selective herbicides: where W is a substituted heterocyclic selected from: wherein A is O or S: halo is chloro, bromo or fluoro; R1 and R2 are the same or different radicals seiectea from hydrogen or (C1-C4) alkyl; X is hydrogen or halo: X1 is methylene. O or S; Z is carboxy, alkoxyalkoxy, alkoxycarbonyl. alkoxycarbonylalkoxycarbonyl, alkoxyalkoxycarbonyl, acyloxy, acylalkoxy. cyanoalkoxy, alkylthioalkoxy, alkoxycarbonylalkoxy, alkoxycarbonylalkenyloxy, a 5- to 6-membered heterocyclic, formylalkoxy. haloalkoxy, mononuclear arylcarbonyalkoxy, oxiranylalkoxy, ammo. monoalkyl amino. dialkylamino, hydrazino, monoal- kythydrazino, dialkylhydrazino, acyiamino. alkoxyamino, alkoxycarbonylamino, mono- or dialkylcarbonylamino, N-alkyl-N-al- koxyalkylaminocarbonylamino, haloalkylcarbonylamino, N-alkylsulfonylaminocarbonyl, N-alkylsulfonylamino, monoalkenylamino, dialkenylamino, monoalkynylamino, dialkynylamino, N-alkyl-N-alkenylamino, or N-alkyl-N-alkynylamino: R is hydrogen or (C1-C4)alkyl and R3 ana R4 are the same or different and are selected from hydrogen. (C1-C4)-alkyl, (C3-C5)alkenyl or (C3-C5)alkynyl.

  下式化合物被公开为选择性除草剂： 式中 W 是选自下列化合物的取代杂环： 其中 A 是 O 或 S：卤素是氯、溴或氟；R1 和 R2 是由氢或（C1-C4）烷基分离出来的相同或不同的基；X 是氢或卤素：X1 是亚甲基。O或S；Z是羧基、烷氧基烷氧基、烷氧羰基、烷氧羰基烷氧羰基、烷氧烷氧羰基、酰氧基、酰基烷氧基、氰基烷氧基、烷硫基烷氧基、烷氧羰基烷氧基、烷氧羰基烯氧基、5-6元杂环、甲酰基烷氧基、卤代烷氧基、单核烷氧基。单烷基氨基、二烷基氨基、肼基、单醛基肼基、二烷基肼基、酰氨基、烷氧基氨基、烷氧基羰基烷氧基、烷氧基羰基烯氧基、5 至 6 元杂环、甲酰基烷氧基、卤代烷氧基、单核芳基羰基烷氧基、环氧乙烷烷氧基、酰胺。烷氧基氨基、烷氧基羰基氨基、单烷基或二烷基羰基氨基、N-烷基-N-烷氧基烷基氨基羰基氨基、卤代烷基羰基氨基、N-烷基磺酰基氨基羰基、N-烷基磺酰基氨基、单烯基氨基、二烯基氨基、单炔基氨基、二炔基氨基、N-烷基-N-烯基氨基或 N-烷基-N-炔基氨基：R是氢或(C1-C4)烷基，R3和R4相同或不同，选自氢。(C1-C4)-烷基、(C3-C5)烯基或(C3-C5)炔基。